You are here

Watch Your Step: Understanding Common Antitrust Risks in the Medical Device Industry

January 22, 2020

Medical device companies must navigate tricky regulatory and legal waters, including compliance with the antitrust laws.  Companies with significant market share are subject to increased scrutiny and even smaller companies must play by the rules or risk government enforcement actions and/or private lawsuits.  The antitrust laws impact how companies can conduct day-to-day business and whether or how they can enter into joint ventures or strategic M&A deals.  This webinar will provide antitrust basics and practical guidance to industry professionals looking to spot potential risks before they become real problems, with a particular focus on how the antitrust laws are applied in the medical device space.    

Julia Vax
Julia Vax focuses her practice on corporate and securities laws in representing emerging growth and public companies, primarily in the life sciences and technology sectors, from formation and early-stage capital raising to publicly traded entities. Ms. Vax has advised clients in the biopharmaceutical, genomics, medical device, diagnostics, Internet and digital media, software, IP telephony, telecommunications and financial services sectors in all aspects of their corporate development and in connection with a broad range of financing and strategic transactions. Ms. Vax has extensive experience in IPOs, Rule 144A transactions, shelf registrations, private placements, including PIPE transactions and venture capital financings, as well as in executive compensation, corporate governance and SEC reporting and compliance for public companies. She has been involved in numerous public and private financing transactions representing companies, investors, underwriters and placement agents.

Pete Levitas
Pete Levitas has more than 25 years of experience as an antitrust lawyer addressing and resolving complex merger and conduct issues, particularly those affecting the healthcare, pharmaceutical, and technology sectors. Mr. Levitas has served in a wide range of US government positions; most recently, he served for more than four years in the role of Deputy Director in the Bureau of Competition at the Federal Trade Commission (FTC) (2009-2013), where he was responsible for the Mergers 1, Health Care and Anticompetitive Practices divisions, as well as the FTC's Northeast Regional Office in New York.

Karen Rigberg
Karen Rigberg brings to her practice years of experience meeting business goals and client needs. As former Managing Counsel for Toyota Motor Sales, Ms. Rigberg was responsible for antitrust compliance, consumer protection, participation agreements, and contract compliance issues. During her time at Toyota, she handled transactions and agreements, including participation, services, supply, and car sharing programs. In that role, Ms. Rigberg was significantly involved in antitrust compliance, training, claims, litigation, consumer protection, and other matters. Prior to 2005, she handled product class actions, trademark enforcement claims, and product liability, and supervised all US warranty and Lemon Law work for the corporation.

Kim Elting
Kim Elting joined the Orthofix Leadership team as Chief Legal Officer in September 2016 and was named Chief Legal and Administrative Officer in 2017. Kim oversees the Legal, Regulatory, Quality, and Corporate Communications teams for the Company. A seasoned executive, she has a strong background in the medical device industry. Before coming to Orthofix, Kim served as General Counsel and Vice President Corporate Affairs at TriVascular Technologies, Inc. In this role, she led the legal, compliance, human resources (HR) and government affairs functions for the company. Prior to this, Kim served in various roles of increasing responsibility with St. Jude Medical including General Counsel and Vice President of HR and Health Policy for the Neuromodulation Division. Kim previously was a partner at the Jones Day law firm. A graduate of Ithaca College, Kim earned her Law Degree from the University of Denver and an LL.M. in Health Law from Loyola University Chicago.